Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Amgen Drug Cuts Cholesterol Levels In Pivotal Studies
Amgen Drug Cuts Cholesterol Levels In Pivotal Studies
Amgen Drug Cuts Cholesterol Levels In Pivotal Studies
Submitted by
admin
on March 31, 2014 - 10:18am
Source:
TheStreet.com
News Tags:
Amgen
cholesterol
evolocumab
Headline:
Amgen Drug Cuts Cholesterol Levels In Pivotal Studies
Do Not Allow Advertisers to Use My Personal information
